A randomised trial comparing combination chemotherapy using mitomycin C, mitozantrone and methotrexate (3M) with vincristine, anthracycline and cyclophosphamide (VAC) in advanced breast cancer
TJ Powles, Alison Jones, I. R. Judson et al. · British Journal of Cancer · 1991
Cited by 35 works. doi:10.1038/bjc.1991.318 Open-access PDF
Authors
References
- Nonparametric Estimation from Incomplete Observations
- Nonparametric Estimation from Incomplete Observations
- Assessment of response to therapy in advanced breast cancer
- Improving the Quality of Life during Chemotherapy for Advanced Breast Cancer
- FAILURE OF CHEMOTHERAPY TO PROLONG SURVIVAL IN A GROUP OF PATIENTS WITH METASTATIC BREAST CANCER
- A randomized trial of two dose levels of cyclophosphamide, methotrexate, and fluorouracil chemotherapy for patients with metastatic breast cancer.
- Assessment of response to therapy in advanced breast cancer
- Combination Chemotherapy for Advanced Breast Cancer: Response and Effect on Survival
- Integration of chemotherapy into combined modality treatment of solid tumors
- Chemotherapy of disseminated breast cancer:Current status and prospects